These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 29980186)

  • 1. Thoracic injection of low-dose interleukin-2 as an adjuvant therapy improves the control of the malignant pleural effusions: a systematic review and meta-analysis base on Chinese patients.
    Han L; Jiang Q; Yao W; Fu T; Zeng Q
    BMC Cancer; 2018 Jul; 18(1):725. PubMed ID: 29980186
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of Efficacy and Safety for Lentinan in the Control of the Malignant Pleural Effusions via Intrapleural Injection.
    Congcong Q; Hengting Z; Shuhui L; Fang Y; Shan W
    Am J Med Sci; 2019 Dec; 358(6):400-411. PubMed ID: 31813467
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thoracic perfusion of recombinant human endostatin (Endostar) combined with chemotherapeutic agents versus chemotherapeutic agents alone for treating malignant pleural effusions: a systematic evaluation and meta-analysis.
    Biaoxue R; Xiguang C; Hua L; Wenlong G; Shuanying Y
    BMC Cancer; 2016 Nov; 16(1):888. PubMed ID: 27842514
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of efficacy and safety for Brucea javanica oil emulsion in the control of the malignant pleural effusions via thoracic perfusion.
    Fuhong D; Xiang G; Haiying L; Jiangye W; Xueming G; Wenxiao C
    BMC Cancer; 2018 Apr; 18(1):411. PubMed ID: 29649989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low-Frequency Sonophoresis of Chinese Medicine Formula Improves Efficacy of Malignant Pleural Effusion Treatment.
    Tian AP; Yin YK; Yu L; Yang BY; Li N; Li JY; Bian ZM; Hu SY; Weng CX; Feng L
    Chin J Integr Med; 2020 Apr; 26(4):263-269. PubMed ID: 31444669
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thoracic perfusion of recombinant mutant human tumor necrosis factor (rmhTNF) can be considered as a good adjunct in the treatment of malignant pleural effusion caused by lung cancer.
    Fu T; Lin Y; Zeng Q; Yao W; Han L
    BMC Pulm Med; 2020 Jun; 20(1):175. PubMed ID: 32552897
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of Efficacy and Safety for Kanglaite Injection in the Control of the Malignant Pleural Effusions via Thoracic Perfusion: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    Zhu G; Wang X; Li J; Zhang Y; Gao R; Zhang X; Xu B; Hu J; Dai M; Chen J
    Front Pharmacol; 2021; 12():694129. PubMed ID: 34803667
    [No Abstract]   [Full Text] [Related]  

  • 8. Thoracic perfusion of lobaplatin combined with endostar for treating malignant pleural effusions: A meta-analysis and systematic review.
    Wang CQ; Liu FY; Wang W
    Medicine (Baltimore); 2022 Oct; 101(40):e30749. PubMed ID: 36221355
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Investigation on the efficiency of lentinan for injection combining cisplatin on treating malignant pleural effusion based on systematic review and meta-analysis.
    Wang Y; Wang H; Chai K; Guo S; Gao Y; Li J; Qiao C; Yang S; Zhou J; Lin Y; Zhang X; Wu J
    Medicine (Baltimore); 2024 May; 103(21):e38032. PubMed ID: 38788041
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of efficacy and safety for recombinant human adenovirus-p53 in the control of the malignant pleural effusions via thoracic perfusion.
    Biaoxue R; Hui P; Wenlong G; Shuanying Y
    Sci Rep; 2016 Dec; 6():39355. PubMed ID: 27976709
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The evidence framework of traditional Chinese medicine injection (Aidi injection) in controlling malignant pleural effusion: A clustered systematic review and meta-analysis.
    Wang CQ; Xu J; Jiang H; Zheng XT; Zhang Y; Huang XR; She F; Fan TY; Zhan L; Feng JH; Gong QH; Xiao X; Chen XF; Xiao Z
    Phytomedicine; 2023 Jul; 115():154847. PubMed ID: 37149965
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A Meta-Analysis of Efficacy and Adverse Effects of Lobaplatin and Cisplatin in the Treatment of Malignant Pleural Effusion].
    Min S; Zheng Q; Zhang B; Yan D; Wang R; Qu Z; Li L; Liu J; Zhou Q
    Zhongguo Fei Ai Za Zhi; 2019 Feb; 22(2):90-98. PubMed ID: 30827325
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intrapleural combination therapy with bevacizumab and cisplatin for non-small cell lung cancer‑mediated malignant pleural effusion.
    Du N; Li X; Li F; Zhao H; Fan Z; Ma J; Fu Y; Kang H
    Oncol Rep; 2013 Jun; 29(6):2332-40. PubMed ID: 23525453
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Previous Radiotherapy Increases the Efficacy of IL-2 in Malignant Pleural Effusion: Potential Evidence of a Radio-Memory Effect?
    Chen D; Song X; Wang H; Gao Z; Meng W; Chen S; Ma Y; Wang Y; Li K; Yu J; Yue J
    Front Immunol; 2018; 9():2916. PubMed ID: 30619280
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetic evaluation of intrapleural perfusion with hyperthermic chemotherapy using cisplatin in patients with malignant pleural effusion.
    Sakaguchi H; Ishida H; Nitanda H; Yamazaki N; Kaneko K; Kobayashi K
    Lung Cancer; 2017 Feb; 104():70-74. PubMed ID: 28213004
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thoracic perfusion of matrine as an adjuvant treatment improves the control of the malignant pleural effusions.
    Biaoxue R; Shuxia M; Wenlong G; Shuanying Y
    World J Surg Oncol; 2015 Dec; 13():329. PubMed ID: 26631104
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intraperitoneal infusion of recombinant human endostatin improves prognosis in gastric cancer ascites.
    Zhan Z; Wang X; Yu J; Zheng J; Zeng Y; Sun M; Peng L; Guo Z; Chen B
    Future Oncol; 2022 Mar; 18(10):1259-1271. PubMed ID: 35114805
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intrapleural cisplatin and cytarabine in the management of malignant pleural effusions: a Lung Cancer Study Group trial.
    Rusch VW; Figlin R; Godwin D; Piantadosi S
    J Clin Oncol; 1991 Feb; 9(2):313-9. PubMed ID: 1988578
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of thoracic hyperthermic perfusion with recombinant human endostatin plus nedaplatin in treating pleural effusion in patients with advanced non-small cell lung cancer.
    Chen L; Zhu X; Li D; Cai X
    J BUON; 2020; 25(6):2643-2649. PubMed ID: 33455108
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of endostar combined with cisplatin in treatment of non-small cell lung cancer with malignant pleural effusion: A meta-analysis.
    Hu Y; Zhou Z; Luo M
    Medicine (Baltimore); 2022 Dec; 101(52):e32207. PubMed ID: 36595983
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.